{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:55Z","timestamp":1781927575867,"version":"3.54.5"},"reference-count":25,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.26-0018","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:09:53Z","timestamp":1781820593000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Unresectable Ampulla of Vater Carcinoma Successfully Treated with Conversion Surgery Following Sequential Systemic Chemotherapy Including Durvalumab"],"prefix":"10.70352","volume":"12","author":[{"given":"Tatsuhiro","family":"Araki","sequence":"first","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Muranushi","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Fukasawa","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuko","family":"Tohmatsu","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Shirai","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaku","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Hirabayashi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-1911","authenticated-orcid":false,"given":"Tsutomu","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Romiti A, Barucca V, Zullo A, et al. Tumors of ampulla of Vater: a case series and review of chemotherapy options. World J Gastrointest Oncol 2012; 4: 60\u20137.","DOI":"10.4251\/wjgo.v4.i3.60"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Williams JL, Chan CK, Toste PA, et al. Association of histopathologic phenotype of periampullary adenocarcinomas with survival. JAMA Surg 2017; 152: 82\u20138.","DOI":"10.1001\/jamasurg.2016.3466"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ishihara S, Horiguchi A, Miyakawa S, et al. Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci 2016; 23: 149\u201357.","DOI":"10.1002\/jhbp.314"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273\u201381.","DOI":"10.1056\/NEJMoa0908721"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mizusawa J, Morizane C, Okusaka T, et al. Randomized phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT). Jpn J Clin Oncol 2016; 46: 385\u20138.","DOI":"10.1093\/jjco\/hyv213"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid 2022; 1: EVIDoa2200015.","DOI":"10.1056\/EVIDoa2200015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ioka T, Kanai M, Kobayashi S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J Hepatobiliary Pancreat Sci 2023; 30: 102\u201310.","DOI":"10.1002\/jhbp.1219"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kimura N, Igarashi T, Murotani K, et al. Novel choledochojejunostomy technique \u201cT-shaped anastomosis\u201d for preventing the development of postoperative cholangitis in pancreatoduodenectomy: a propensity score matching analysis. Ann Gastroenterol Surg 2024; 8: 301\u201311.","DOI":"10.1002\/ags3.12744"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yabushita Y, Park JS, Yoon YS, et al. Conversion surgery for initially unresectable locally advanced biliary tract cancer: a multicenter collaborative study conducted in Japan and Korea. J Hepatobiliary Pancreat Sci 2024; 31: 481\u201391.","DOI":"10.1002\/jhbp.1437"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ueno M, Shirakawa S, Tokumaru J, et al. Real-world evidence of systemic treatment practices for biliary tract cancer in Japan: results of a database study. J Hepatobiliary Pancreat Sci 2024; 31: 468\u201380.","DOI":"10.1002\/jhbp.1418"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Bird N, Elmasry M, Jones R, et al. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma. Br J Surg 2017; 104: 418\u201325.","DOI":"10.1002\/bjs.10399"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Davidson JT 4th, Jin LX, Krasnick B, et al. Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions. J Surg Oncol 2019; 119: 288\u201394.","DOI":"10.1002\/jso.25323"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kobayashi S, Tomokuni A, Takahashi H, et al. Laparoscopic hilar lymph node sampling in patients with biliary tract cancers that are rarely associated with nodal metastasis. Surg Laparosc Endosc Percutan Tech 2018; 28: 90\u20135.","DOI":"10.1097\/SLE.0000000000000510"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tilleman EH, de Castro SM, Busch OR, et al. Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. J Gastrointest Surg 2002; 6: 426\u201331.","DOI":"10.1016\/S1091-255X(02)00005-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bhardwaj N, Garcea G, Dennison AR, et al. The surgical management of Klatskin tumours: has anything changed in the last decade? World J Surg 2015; 39: 2748\u201356.","DOI":"10.1007\/s00268-015-3125-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hashimoto Y, Ajiki T, Yanagimoto H, et al. Risk factors for occult metastasis detected by inflammation-based prognostic scores and tumor markers in biliary tract cancer. World J Clin Cases 2021; 9: 9770\u201382.","DOI":"10.12998\/wjcc.v9.i32.9770"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakamura I, Hatano E, Baba H, et al. Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer. Ann Gastroenterol Surg 2023; 7: 1009\u201320.","DOI":"10.1002\/ags3.12713"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fujii W, Hayashi K, Yamada S, et al. Curative resection of carcinoma of the ampulla of Vater with lymph node metastases around the abdominal aorta after chemotherapy: a case report. Int J Surg Case Rep 2016; 28: 274\u20138.","DOI":"10.1016\/j.ijscr.2016.09.050"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sato Y, Hara T, Takami Y, et al. Conversion surgery for initially unresectable carcinoma of the ampulla of Vater following pathological complete response to chemotherapy: a case report. Surg Case Rep 2019; 5: 122.","DOI":"10.1186\/s40792-019-0680-z"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tomino T, Sugimachi K, Kakimoto T, et al. Conversion surgery after complete response to immune checkpoint inhibitor-based sequential chemotherapy for initially unresectable perihilar cholangiocarcinoma: a case report. Surg Case Rep 2025; 11: 25-0555.","DOI":"10.70352\/scrj.cr.25-0555"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Liu C, Fang F, Kong Y, et al. Tumor area positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring. Diagn Pathol 2023; 18: 48.","DOI":"10.1186\/s13000-023-01318-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Zhang S, Nie J, Tai S, et al. PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer. BMJ Case Rep 2023; 16: e255403.","DOI":"10.1136\/bcr-2023-255403"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Araki T, Muranushi R, Takagi K, et al. A case of successful conversion surgery for unresectable gallbladder cancer treated with durvalumab in combination with gemcitabine plus cisplatin. Clin J Gastroenterol 2025; 18: 161\u20138.","DOI":"10.1007\/s12328-024-02053-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ioka T, Shindo Y, Ueno M, et al. Current progress in perioperative chemotherapy for biliary tract cancer. Ann Gastroenterol Surg 2023; 7: 565\u201371.","DOI":"10.1002\/ags3.12691"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sangro B, Chan SL, Kelley RK, et al. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. Ann Oncol 2024; 35: 448\u201357.","DOI":"10.1016\/j.annonc.2024.02.005"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:40:16Z","timestamp":1781926816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.26-0018","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.26-0018"}}